10/8/2024 10:49:47 AM Introduction to the DLA Piper Genomics Series: An Insight into the ‘Genomics Revolution’ By Marion Abecassis Lyndsey Hudson Kate Black Ruth Faragher +1 more... Show less Introduction Over the next 2 months, the DLA Piper Life Sciences Blog: Cortex will feature a series of articles providing an insight into...
2/4/2025 4:25:05 PM Poland - Life Sciences Monthly Brief, January 2025 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our November monthly briefing, which covers key updates and insights in the following areas: Medicinal...
1/24/2025 9:45:56 AM The Transformative Impact of Technology Innovation on the Life Sciences Industry in 2025 By Chloe Forster In 2024, our Life Sciences Index, Tech Index and "Predictions for Life Sciences in 2025" all highlighted the growing role of technology...
1/10/2025 2:31:57 PM Life Sciences News in Italy: December 2024 By DLA Piper Life Sciences Spotlight: Launch of the Master's Program in Pharmaceutical and Health Law We're pleased to announce we've launched the Master's Program...
1/9/2025 11:32:10 AM Poland - Life Sciences Monthly Brief, December 2024 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our December monthly briefing, which covers key updates and insights in the following areas: Medicinal...
12/19/2024 11:12:39 PM Our Predictions for Life Sciences in 2025 By DLA Piper Life Sciences As the New Year is fast approaching, we asked members of our Life Sciences team to share their predictions of what will be the key issues...
12/17/2024 12:41:43 PM Spanish Pharmaceutical Industry Strategy 2024-2028: Strengthening Access, Innovation, and Sustainability By Elisa Lorenzo On 10 December 2024, the Spanish Government officially unveiled the Pharmaceutical Industry Strategy 2024-2028 ("the Strategy"), a...
12/16/2024 9:33:01 AM NIS2 Series, Part 3 - What happens if you don’t comply? An overview of enforcement, supervisory measures, and liability for management bodies By Andreas Rüdiger Philipp Adelberg Introduction The NIS2 Directive (NIS2 or the Directive) introduces extensive new cybersecurity requirements for a wide range of...
12/10/2024 12:34:50 PM Poland - Life Sciences Monthly Brief, November 2024 By DLA Piper Life Sciences Download a copy of our November monthly briefing, which covers key updates and insights in the following areas: Medicinal...
12/10/2024 10:33:06 AM Life Sciences News in Italy: November 2024 By DLA Piper Life Sciences Regulatory MDCG updates Q&A on vigilance terms under MDR and IVDR On 11 November 2024, the Medical Device Coordination Group (MDCG)...
12/4/2024 9:05:43 AM What should in-scope organisations do now to prepare for NIS2 compliance? By Cristina Criscuoli Federico Toscani Introduction In our second Network and Information Systems Directive (NIS2 Directive or Directive) article, we discuss the significant...
12/4/2024 9:05:29 AM DLA Piper Genomics Series: Shaping the Future of Genomics - How Governments Worldwide Are Driving the Shift to Personalised Medicine By Kate Black As our Genomics mini-series has been exploring to date, genomic medicine is rapidly transforming healthcare across the globe, offering...
11/20/2024 9:20:17 AM EHDS – Access to health data for secondary use under the European Health Data Space By Andreas Rüdiger James Clark This is Part 3 in a series of articles on the European Health Data Space ("EHDS"). Part 1 provides a general overview of the EHDS. Part...
11/19/2024 2:21:18 PM DLA Piper Genomics Series: The UAE turns to genomics to provide world-class healthcare services By Adam Vause Celia Johnson-Morgan Katie Edwards Harnessing genomic technologies is revolutionising patient care by powering the evolution of personalised and precision medicine. The...
11/12/2024 9:47:00 AM DLA Piper Genomics Series: CRISPR/Cas patent disputes – the position in Australia By Nicholas Tyacke Alex May The development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein (Cas) systems for genome...
11/5/2024 9:43:08 AM Poland - Life Sciences Monthly Brief, October 2024 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our July monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...
10/31/2024 4:30:17 PM Medicines Australia Code of Conduct – New Edition Released By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Hazel Pang +1 more... Show less On 30 October 2024, Medicines Australia (MA) formally adopted a new edition (Edition 20) of the MA Code of Conduct (MA Code), which will...